Europe Body Composition Analyzers Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
The market of Europe Body Composition Analyzers Market is accounted to reach USD 660.9 million by 2024 from USD 363.7 million in 2016, at a CAGR of 7.8%.
The major factors driving the growth of this market are aging population globally, rising obesity globally, government initiatives, and key players are taking strategic decisions to gain market share, increasing health club memberships, growing health and fitness consciousness and increasing diseases due to changing lifestyle.
The key market players for Europe Body Composition Analyzers Market are listed below:
The Europe body composition analyzers market is segmented into 5 types, on the basis of the product type. The 5 types of products are Bio impedance Analyzers (BIA), Dual-Energy X-Ray Absorptiometry (DEXA), Skinfold Calipers, Hydrostatic Weighing (HwD), Air Displacement Plethysmography (ADP).
In 2017, BIA market segment is expected to dominate the market with 76.1% market share and is expected to grow at the highest in the forecast period 2017 to 2024.
On the basis of end-user, the Europe body composition analyzers market is segmented into 4 segments such as hospitals and clinics, corporate settings, health clubs, and other end users.
Based on geography, the Europe Body Composition Analyzers market is segmented into 11 geographical regions, such as,
The report covers the present scenario and the growth prospects of the Europe Body Composition Analyzers market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The major factors driving the growth of this market are aging population globally, rising obesity globally, government initiatives, and key players are taking strategic decisions to gain market share, increasing health club memberships, growing health and fitness consciousness and increasing diseases due to changing lifestyle.
The key market players for Europe Body Composition Analyzers Market are listed below:
- Omron Healthcare, Inc. (Japan)
- Seca (Germany)
- InBody Co., Ltd. (South Korea), ,
- Selvashealthcare (Korea),
- Bodystat (U.K.),
- Hologic, Inc. (U.S.),
- GE Healthcare (U.K.),
- COSMED (Italy),
- Beurer GmbH (Germany),
- RJL Systems (U.S.A),
- Maltron International Ltd. (U.K.),
- Laica (Italy)
- Product
- Application
- End user
- Geography
The Europe body composition analyzers market is segmented into 5 types, on the basis of the product type. The 5 types of products are Bio impedance Analyzers (BIA), Dual-Energy X-Ray Absorptiometry (DEXA), Skinfold Calipers, Hydrostatic Weighing (HwD), Air Displacement Plethysmography (ADP).
In 2017, BIA market segment is expected to dominate the market with 76.1% market share and is expected to grow at the highest in the forecast period 2017 to 2024.
On the basis of end-user, the Europe body composition analyzers market is segmented into 4 segments such as hospitals and clinics, corporate settings, health clubs, and other end users.
Based on geography, the Europe Body Composition Analyzers market is segmented into 11 geographical regions, such as,
- France,
- U.K.,
- Germany
- Italy.
The report covers the present scenario and the growth prospects of the Europe Body Composition Analyzers market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1 INTRODUCTION
1.1. OVERVIEW OF THE EUROPE BODY COMPOSITION ANALYZER MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2 MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE EUROPE BODY COMPOSITION ANALYZERS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET TIME LINE
2.2.4 MARKET GUIDE
2.2.5 COMPANY POSITIONING GRID
2.2.6 COMAPANY MARKET SHARE ANALYSIS
2.2.7 MULTIVARIATE MODELLING
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3. EUROPE BODY COMPOSITION ANALYZERS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1. VENDOR POSITIONING GRID AND INVESTMENT OPPORTUNITIES
5.2. TECHNOLOLGICAL ADVANCEMENTS
5.3. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE NORTH AMERICA RADIOTHERAPYMARKET MARKET
5.4. MARKET REGULATORY SCENARIO BY COUNTRY
5.5. INTERVIEW KEY INSIGHTS
6 EUROPE BODY COMPOSITION ANALYZERS MARKET, BY TYPE
7 EUROPE BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT
8 EUROPE BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION
9 EUROPE BODY COMPOSITION ANALYZERS MARKET, BY END USER
10 EUROPE BODY COMPOSITION ANALYZERS MARKET: GEOGRAPHY
11 EUROPE BODY COMPOSITION ANALYZERS MARKET, COMPANY PROFILES
11.1 OMRON HEALTHCARE, INC. (JAPAN)
11.2 SECA (GERMANY)
11.3 INBODY CO., LTD. (SOUTH KOREA)
11.4 SELVASHEALTHCARE (KOREA)
11.5 BODYSTAT (U.K.)
11.6 COMPANY A
11.7 COMPANY B
11.8 COMPANY C
11.9 COMPANY D
11.10 COMPANY E
11.11 COMPANY F
11.12 COMPANY G
11.13 COMPANY H
11.14 COMPANY I
11.15 COMPANY J
11.16 COMPANY K
11.17 COMPANY M
11.18 COMPANY N
11.19 COMPANY O
12 APPENDIX
13 ABOUT DATA BRIDGE MARKET RESEARCH
1.1. OVERVIEW OF THE EUROPE BODY COMPOSITION ANALYZER MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2 MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE EUROPE BODY COMPOSITION ANALYZERS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET TIME LINE
2.2.4 MARKET GUIDE
2.2.5 COMPANY POSITIONING GRID
2.2.6 COMAPANY MARKET SHARE ANALYSIS
2.2.7 MULTIVARIATE MODELLING
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3. EUROPE BODY COMPOSITION ANALYZERS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1. VENDOR POSITIONING GRID AND INVESTMENT OPPORTUNITIES
5.2. TECHNOLOLGICAL ADVANCEMENTS
5.3. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE NORTH AMERICA RADIOTHERAPYMARKET MARKET
5.4. MARKET REGULATORY SCENARIO BY COUNTRY
5.5. INTERVIEW KEY INSIGHTS
6 EUROPE BODY COMPOSITION ANALYZERS MARKET, BY TYPE
7 EUROPE BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT
8 EUROPE BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION
9 EUROPE BODY COMPOSITION ANALYZERS MARKET, BY END USER
10 EUROPE BODY COMPOSITION ANALYZERS MARKET: GEOGRAPHY
11 EUROPE BODY COMPOSITION ANALYZERS MARKET, COMPANY PROFILES
11.1 OMRON HEALTHCARE, INC. (JAPAN)
11.2 SECA (GERMANY)
11.3 INBODY CO., LTD. (SOUTH KOREA)
11.4 SELVASHEALTHCARE (KOREA)
11.5 BODYSTAT (U.K.)
11.6 COMPANY A
11.7 COMPANY B
11.8 COMPANY C
11.9 COMPANY D
11.10 COMPANY E
11.11 COMPANY F
11.12 COMPANY G
11.13 COMPANY H
11.14 COMPANY I
11.15 COMPANY J
11.16 COMPANY K
11.17 COMPANY M
11.18 COMPANY N
11.19 COMPANY O
12 APPENDIX
13 ABOUT DATA BRIDGE MARKET RESEARCH
